Deborah Ayeni

440 total citations
7 papers, 211 citations indexed

About

Deborah Ayeni is a scholar working on Pulmonary and Respiratory Medicine, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Deborah Ayeni has authored 7 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Deborah Ayeni's work include Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Deborah Ayeni is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Deborah Ayeni collaborates with scholars based in United States, Switzerland and India. Deborah Ayeni's co-authors include Katerina Politi, Thomas J. Lynch, Samir Mandal, Barbara Zajc, Robert Homer, Basavaraju G. Sanganahalli, Valentina Pirazzoli, William Pao, Fahmeed Hyder and Catherine B. Meador and has published in prestigious journals such as Cancer Cell, Clinical Cancer Research and Tetrahedron Letters.

In The Last Decade

Deborah Ayeni

7 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Ayeni United States	6	118	98	91	55	27	7	211
Yinglei Gao China	12	194 1.6×	52 0.5×	101 1.1×	38 0.7×	57 2.1×	21	296
Meizhong Xu United States	5	134 1.1×	75 0.8×	74 0.8×	50 0.9×	61 2.3×	5	295
Hirokazu Ohsawa Japan	7	192 1.6×	90 0.9×	120 1.3×	25 0.5×	29 1.1×	11	334
Jared Bearss United States	6	164 1.4×	66 0.7×	60 0.7×	25 0.5×	34 1.3×	11	286
Matthew T. DiMare United States	6	190 1.6×	56 0.6×	130 1.4×	49 0.9×	46 1.7×	7	320
Vandana Sandhu Norway	9	129 1.1×	47 0.5×	107 1.2×	123 2.2×	8 0.3×	11	251
Venkataswamy Sorna United States	5	285 2.4×	69 0.7×	45 0.5×	25 0.5×	43 1.6×	6	358
Hiromi Tanimura United States	8	205 1.7×	136 1.4×	148 1.6×	26 0.5×	42 1.6×	9	353

Countries citing papers authored by Deborah Ayeni

Since Specialization

Citations

This map shows the geographic impact of Deborah Ayeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Ayeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Ayeni more than expected).

Fields of papers citing papers by Deborah Ayeni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Ayeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Ayeni. The network helps show where Deborah Ayeni may publish in the future.

Co-authorship network of co-authors of Deborah Ayeni

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Ayeni. A scholar is included among the top collaborators of Deborah Ayeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Ayeni. Deborah Ayeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cordes, Thekla, Ziyan Xu, Ramya S. Kuna, et al.. (2024). EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth. Cancer Discovery. 14(3). 524–545. 19 indexed citations

2.

Foggetti, Giorgia, Chuan Li, Hongchen Cai, et al.. (2021). Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer Discovery. 11(7). 1736–1753. 68 indexed citations

3.

Ayeni, Deborah, et al.. (2021). Elevated murine HB-EGF confers sensitivity to diphtheria toxin in EGFR-mutant lung adenocarcinoma. Disease Models & Mechanisms. 14(11). 1 indexed citations

4.

Ayeni, Deborah, Ping‐Chih Ho, Fernando J. de Miguel, et al.. (2019). Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors. Journal for ImmunoTherapy of Cancer. 7(1). 172–172. 24 indexed citations

5.

Pirazzoli, Valentina, Deborah Ayeni, Catherine B. Meador, et al.. (2015). Afatinib plus Cetuximab Delays Resistance Compared to Single-Agent Erlotinib or Afatinib in Mouse Models of TKI-Naïve EGFR L858R-Induced Lung Adenocarcinoma. Clinical Cancer Research. 22(2). 426–435. 32 indexed citations

6.

Politi, Katerina, Deborah Ayeni, & Thomas J. Lynch. (2015). The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic. Cancer Cell. 27(6). 751–753. 50 indexed citations

7.

Ayeni, Deborah, Samir Mandal, & Barbara Zajc. (2013). Julia–Kocienski approach to trifluoromethyl-substituted alkenes. Tetrahedron Letters. 54(45). 6008–6011. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact